MINI FUTURE SHORT - BRISTOL-MYERS SQUIBB | Delayed Börse Stuttgart 16:23:00 23/05/2024 BST | ||
| 4.06 EUR | +1.25% |
|
| Current month | +2.82% | ||
| 1 month | +16.91% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 4.06 | +1.25% |
| 22/05/24 | 4.01 | +0.25% |
| 21/05/24 | 4 | +2.83% |
| 20/05/24 | 3.89 | +1.57% |
| 17/05/24 | 3.83 | 0.00% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 04:23 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Morgan Stanley |
| WKN | MB979C |
| ISIN | DE000MB979C5 |
| Date issued | 27/07/2023 |
| Strike | 85.77 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.08 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.06 € |
|---|---|
| Lowest since issue | 2.06 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.34
USD
Average target price
53.19
USD
Spread / Average Target
+25.64%
- Stock Market
- Certificates
- Certificat
